Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Hanauer

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Expert Review of Clinical Immunology|May 22, 2012
Management of inflammatory bowel disease: past, present and futureKian Keyashian, Maria Laura Annunziata, Atsushi Sakuraba, et al.
Current Gastroenterology Reports|April 18, 2016
Integrating Adolescents and Young Adults into Adult-Centered Care for IBDItishree Trivedi, Jane L Holl, Stephen Hanauer, et al.
The Cochrane Database of Systematic Reviews|July 4, 2016
Aminosalicylates for induction of remission or response in Crohn's diseaseWee-Chian Lim, Yongjun Wang, John K MacDonald, et al.
BMJ Open Gastroenterology|September 26, 2017
Prevalence and screening for anaemia in mild to moderate Crohn's disease and ulcerative colitis in the United States, 2010-2014Eboselume Akhuemonkhan, Alyssa Parian, Kay Miller, et al.
Journal of Clinical Gastroenterology|April 9, 2005
Unemployment and disability in patients with moderately to severely active Crohn's diseaseBrian G Feagan, Mohan Bala, Songkai Yan, et al.
Crohn'S & Colitis 360|June 29, 2026
The association between 6-thioguanine nucleotide levels, adalimumab exposure, immune response, and drug clearanceAndres Yarur, Jonathan C Lo, Bincy Abraham, et al.
The Lancet. Gastroenterology & Hepatology|August 13, 2021
Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trialStephen Hanauer, Bernd Liedert, Sigrid Balser, et al.
Inflammatory Bowel Diseases|October 12, 2004
Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease expertsGary R Lichtenstein, Carmen Cuffari, Sunanda V Kane, et al.
Inflammatory Bowel Diseases|April 4, 2014
AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled studyWalter Reinisch, Simon Travis, Stephen Hanauer, et al.
Journal of Crohn'S & Colitis|April 3, 2012
What changes in inflammatory bowel disease management can be implemented today?Edouard Louis, Daniel C Baumgart, Subrata Ghosh, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Expert Review of Clinical Immunology|May 22, 2012
Management of inflammatory bowel disease: past, present and futureKian Keyashian, Maria Laura Annunziata, Atsushi Sakuraba, et al.
Current Gastroenterology Reports|April 18, 2016
Integrating Adolescents and Young Adults into Adult-Centered Care for IBDItishree Trivedi, Jane L Holl, Stephen Hanauer, et al.
The Cochrane Database of Systematic Reviews|July 4, 2016
Aminosalicylates for induction of remission or response in Crohn's diseaseWee-Chian Lim, Yongjun Wang, John K MacDonald, et al.
BMJ Open Gastroenterology|September 26, 2017
Prevalence and screening for anaemia in mild to moderate Crohn's disease and ulcerative colitis in the United States, 2010-2014Eboselume Akhuemonkhan, Alyssa Parian, Kay Miller, et al.
Journal of Clinical Gastroenterology|April 9, 2005
Unemployment and disability in patients with moderately to severely active Crohn's diseaseBrian G Feagan, Mohan Bala, Songkai Yan, et al.
Crohn'S & Colitis 360|June 29, 2026
The association between 6-thioguanine nucleotide levels, adalimumab exposure, immune response, and drug clearanceAndres Yarur, Jonathan C Lo, Bincy Abraham, et al.
The Lancet. Gastroenterology & Hepatology|August 13, 2021
Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trialStephen Hanauer, Bernd Liedert, Sigrid Balser, et al.
Inflammatory Bowel Diseases|October 12, 2004
Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease expertsGary R Lichtenstein, Carmen Cuffari, Sunanda V Kane, et al.
Inflammatory Bowel Diseases|April 4, 2014
AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled studyWalter Reinisch, Simon Travis, Stephen Hanauer, et al.
Journal of Crohn'S & Colitis|April 3, 2012
What changes in inflammatory bowel disease management can be implemented today?Edouard Louis, Daniel C Baumgart, Subrata Ghosh, et al.
Pageof 7